|
Cannabicyclol
|
|
| Systematic (IUPAC) name | |
| (1aR-(1a alpha,3a alpha,8b alpha,8c alpha))- 1a,2,3,3a, 8b,8c-hexahydro-1,1,3a-trimethyl -6- pentyl-1H-4-oxabenzo (f)cyclobut(cd)inden-8-ol |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C21H30O2 |
| Mol. mass | 314.462 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Cannabicyclol, also known as CBL, is a non-psychoactive cannabinoid found in the Cannabis species. CBL is a degradative product like Cannabinol. Light converts Cannabichromene to CBL.
CDB in Cannabis is known to induce sleep. The Cannabis indica strain contains overall more CBL than Cannabis Sativa strains.